NXY-059, a Free Radical–Trapping Agent, Substantially Lessens the Functional Disability Resulting From Cerebral Ischemia in a Primate Species
Year: 2001
Type: article
Source: Stroke
Authors: Jonathan W. B. Marshall, Katharine J. Duffin, A. Richard Green, Rosalind M. Ridley
Institutions: AstraZeneca (United Kingdom), University of Cambridge
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
Funders: Wellcome Trust, Medical Research Council
OpenAlex ID: W2105215015
